RARE icon

Ultragenyx Pharmaceutical
RARE

Upgrade to unlock
Buy
Hold
Sell

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$52
127% upside
High target

10 analyst ratings

positive
1  neutral
10%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Canaccord Genuity
Canaccord Genuity
Whitney Ijem
50% 1-yr RARE win rate
18 Feb ‘26 12 days ago
Evercore ISI Group
Evercore ISI Group
Liisa Bayko
50% 1-yr RARE win rate
18 Feb ‘26 12 days ago
Wedbush
Wedbush
Laura Chico
17 Feb ‘26 13 days ago
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
60% 1-yr RARE win rate
17 Feb ‘26 13 days ago
Guggenheim
Guggenheim
Debjit Chattopadhyay
0% 1-yr RARE win rate
5 Jan ‘26 1 month ago
BofA Securities
BofA Securities
Tazeen Ahmad
100% 1-yr RARE win rate
2 Jan ‘26 1 month ago
Leerink Partners
Leerink Partners
Joseph Schwartz
100% 1-yr RARE win rate
30 Dec ‘25 2 months ago
Baird
Baird
Joel Beatty
100% 1-yr RARE win rate
30 Dec ‘25 2 months ago
Wells Fargo
Wells Fargo
Benjamin Burnett
100% 1-yr RARE win rate
30 Dec ‘25 2 months ago
Jefferies
Jefferies
Maury Raycroft
100% 1-yr RARE win rate
30 Dec ‘25 2 months ago